|
Diabetes Care, Vol 21, Issue 2 250-255, Copyright © 1998 by American Diabetes Association
Gender, autoantibodies, and obesity in newly diagnosed diabetic patients aged 40-75 years
M Wroblewski, A Gottsater, F Lindgarde, P Fernlund and G Sundkvist
Department of Medicine, Malmo University Hospital, University of Lund, Sweden.
OBJECTIVE: To evaluate the frequency of autoimmune markers (islet cell
antibodies (ICA] and glutamic acid decarboxylase antibodies [GADA]) and
clinical features in newly diagnosed people with diabetes aged 40-75 years.
RESEARCH DESIGN AND METHODS: Two hundred fifty-nine consecutive patients
(aged 40-75 years) with newly suspected diabetes diagnosed during a 2-year
period were studied. The diagnosis of newly discovered diabetes was
confirmed in 203 patients. Gender, BMI, HbA1c, fasting C-peptide, ICA, and
GADA were evaluated. The frequency of obesity was estimated using two
different sets of criteria: 1) National Diabetes Data Group (NDDG)
criteria, and 2) criteria based on a Swedish reference population. RESULTS:
The annual incidence of diabetes was 106 per 100,000 people. The incidence
of diabetes in those patients who were 40-54 years old was significantly
higher in men than in women (odds ratio: 2.16; P = 0.001). ICA were
detected in 16 of 203 patients (8%), whereas 17 of 203 patients (8%) were
GADA+; 10 of 203 (5%) patients were positive for both ICA and GADA. Among
the 203 diabetic patients, 19 (9.4%) were classified as having IDDM, giving
an IDDM incidence of 10 per 100,000 people aged 40-75 years. The frequency
of obesity in NIDDM was high but varied with its definition; the frequency
of obesity was highest (P < 0.001) when NDDG criteria, and not Swedish
reference values, were used (57 of 75 [76%] vs. 40 of 75 [53%] for women
and 66 of 109 [61%] vs. 45 of 109 [41%] for men). CONCLUSIONS: A striking
male preponderance was found among incident cases of diabetes in people
aged 40-54 years. Autoimmune markers were detected in 10% of incident cases
of diabetes in people aged 40-75 years. Using a conservative estimation, as
many as 10 of 100,000 middle-aged and elderly subjects developed IDDM. The
frequency of obesity in NIDDM was high but this was also the case in the
reference population.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S Genovese, E Bazzigaluppi, D Goncalves, A Ciucci, M G Cavallo, F Purrello, M Anello, C M Rotella, G Bardini, O Vaccaro, et al.
Clinical phenotype and {beta}-cell autoimmunity in Italian patients with adult-onset diabetes.
Eur. J. Endocrinol.,
March 1, 2006;
154(3):
441 - 447.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Stenstrom, A. Gottsater, E. Bakhtadze, B. Berger, and G. Sundkvist
Latent Autoimmune Diabetes in Adults: Definition, Prevalence, {beta}-Cell Function, and Treatment
Diabetes,
December 1, 2005;
54(suppl_2):
S68 - S72.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Bruno, C. Runzo, P. Cavallo-Perin, F. Merletti, M. Rivetti, S. Pinach, G. Novelli, M. Trovati, F. Cerutti, G. Pagano, et al.
Incidence of Type 1 and Type 2 Diabetes in Adults Aged 30-49 Years: The population-based registry in the province of Turin, Italy
Diabetes Care,
November 1, 2005;
28(11):
2613 - 2619.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Palmer, G. A. Fleming, C. J. Greenbaum, K. C. Herold, L. D. Jansa, H. Kolb, J. M. Lachin, K. S. Polonsky, P. Pozzilli, J. S. Skyler, et al.
C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve {beta}-Cell Function: Report of an ADA Workshop, 21-22 October 2001
Diabetes,
January 1, 2004;
53(1):
250 - 264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Pozzilli and U. Di Mario
Autoimmune Diabetes Not Requiring Insulin at Diagnosis (Latent Autoimmune Diabetes of the Adult): Definition, characterization, and potential prevention
Diabetes Care,
August 1, 2001;
24(8):
1460 - 1467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Törn, M. Landin-Olsson, A. Lernmark, J. P. Palmer, H. J. Arnqvist, G. Blohmé, F. Lithner, B. Littorin, L. Nyström, B. Scherstén, et al.
Prognostic Factors for the Course of {beta} Cell Function in Autoimmune Diabetes
J. Clin. Endocrinol. Metab.,
December 1, 2000;
85(12):
4619 - 4623.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
O. Pinhas-Hamiel and P. Zeitler
The Importance of a Name
N. Engl. J. Med.,
May 6, 1999;
340(18):
1418 - 1421.
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Diabetes Association.
|
|
| |
|